Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity
Authors not listed
Wake Forest University Health Sciences · 2026
Abstract
This 12-week randomized, double-blind, placebo-controlled trial will test the hypothesis that Vibegron (brand name GEMTESA) can improve energy metabolism, cardiometabolic risk factors, and physical and cognitive function in middle-aged and older adults with obesity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Anonymous. (2026). Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity. <em>Wake Forest University Health Sciences</em>. https://clinicaltrials.gov/study/NCT06987383
Vancouver
Anonymous. Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity. Wake Forest University Health Sciences. 2026.
BibTeX
@misc{anon2026Vibegr,
title = {Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity},
author = {Anonymous},
journal = {Wake Forest University Health Sciences},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Florida 2014
Open access · US-GOV
Role of Methotrexate in Improving Physical Function in Older Adults With Elevated Levels of Inflammation
Elsevier eBooks 1988
Citation only
Senescence and Aging in Plants
University of Colorado, Boulder 2026
Open access · US-GOV
Targeting Cellular Senescence With Fisetin for Improving Vascular Endothelial Function in Older Adults
GeroScience 2023
Preprint · OA
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment
Shirley Ryan AbilityLab 2018
Open access · US-GOV
Implementing a Robotic Hip Assist-based Mobility Intervention for Older Adults With Frailty
VA Office of Research and Development 2021
Open access · US-GOV